Delivery Order SPE2DB25D3504-SPE2DB25FVWFJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,457.92 to AmerisourceBergen Drug Corp for ZORYVE 0.15% Cream (60 grams) on August 25, 2025, with completion expected by August 26, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitive delivery order award from the Defense Logistics Agency on April 29, 2025, for ZORYVE 0.3% Cream in a 60-gram quantity. This firm fixed-price delivery order, valued at $5,656.30 and due for completion by April 30, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Cream in a 60-gram unit, with a contract ceiling value of $1,088.04. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Cream in a 60-gram quantity, with a contract ceiling value of $2,100.10. This competitively awarded, firm fixed-price delivery order was issued on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for ZORYVE 0.15% Cream in a 60-gram size. This firm fixed-price delivery order, valued at $1,018.11, represents a competitive award with no set-aside designation and carries an ultimate completion date of July 29, 2025. The contract is executed under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,036.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of ZORYVE 0.3% Cream in 60-gram units. This is a non-set-aside contract with an ultimate completion date of April 25, 2025, and performance occurring at the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of ZORYVE 0.3% Cream in 60-gram quantities, with a contract ceiling value of $2,571.76. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,246.51 to AmerisourceBergen Drug Corp for ZORYVE 0.15% Cream 60GM, a topical pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on July 16, 2025, with an ultimate completion date of July 17, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- On June 2, 2025, the Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,858.71 for ZORYVE 0.15% Cream in 60-gram quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 3, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order operates under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Cream 60GM with a ceiling value of $7,270.70. This contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing, with a delivery deadline of July 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVWFJDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,548.75 for ZORYVE 0.3% Cream (60GM) on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract supporting federal medical procurement needs. The award is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. The IDC serves as a global pharmaceutical procurement vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates consistent capability to fulfill diverse medical supply requirements through open competition, ranging from small-value transactions to substantial orders supporting critical military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/5/25 |